Activation of the cardiac interleukin‐6 system in advanced heart failure

[1]  A. Khaghani,et al.  Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. , 2000, Circulation.

[2]  G. Freeman,et al.  beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. , 2000, Circulation.

[3]  H. Scheld,et al.  Reversal of myocardial interleukin-6-mRNA expression following long-term left ventricular assist device support for myocarditis-associated low output syndrome. , 1999, The Journal of Heart and Lung Transplantation.

[4]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[5]  S. Frøland,et al.  Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1999, The American journal of cardiology.

[6]  H. Robenek,et al.  Left-Ventricular Expression of lnterleukin-6 Messenger-RNA Higher in Idiopathic Dilated Than in Ischemic Cardiomyopathy , 1998, The Thoracic and cardiovascular surgeon.

[7]  D. Fukai,et al.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[8]  H. Robenek,et al.  Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  G. Dorn,et al.  Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte* , 1997, The Journal of Biological Chemistry.

[10]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[11]  G. Breithardt,et al.  Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure. , 1996, International journal of cardiology.

[12]  J. Vincent,et al.  Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. , 1996, The Journal of thoracic and cardiovascular surgery.

[13]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[14]  H. Scheld,et al.  Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. , 1996, The Annals of thoracic surgery.

[15]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[16]  M. Munger,et al.  Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1996, The American journal of cardiology.

[17]  D. McGiffin,et al.  Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  K. Shiota,et al.  Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Breithardt,et al.  The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. , 1995, Transplantation.

[20]  M. Entman,et al.  Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. , 1995, Circulation.

[21]  F. Neumann,et al.  Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. , 1995, Circulation.

[22]  T. Kishimoto,et al.  Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Katz.  The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart , 1994, Annals of Internal Medicine.

[24]  M. Yacoub,et al.  Local production of cytokines in the human cardiac allograft. A sequential study. , 1994, Transplantation.

[25]  D. Mann,et al.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.

[26]  R. Simmons,et al.  Interleukin-6 (IL-6) as a mediator of stunned myocardium. , 1993, The American journal of cardiology.

[27]  J. Balligand,et al.  Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. , 1993, The Journal of clinical investigation.

[28]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[29]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[30]  G. Schreiner,et al.  Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes. , 1988, Biochemical and biophysical research communications.

[31]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.